Nicholas Haft
Director, Finch Therapeutics Group, Inc.
Companies
- Finch Therapeutics Group, Inc.Board member Mar 18, 2021 to Jun 9, 20231
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Finch Therapeutics Group, Inc.4,056,907 shares2Dec 20, 2021
As of each latest filing. The line shows shares held over time.
Recent filings
- Dec 20, 2021Bought 63,850 shares at $10.18 of Finch Therapeutics Group, Inc.2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2